LIVE
A 29-amino-acid synthetic peptide identical to the active 1-29 N-terminal fragment of human growth hormone-releasing hormone (CAS 86168-78-7). Agonizes the GHRH receptor to stimulate endogenous pulsatile GH secretion via the hypothalamic-pituitary axis. Originally FDA-approved by EMD Serono as Geref in 1997 for pediatric growth hormone deficiency; commercial application withdrawn in 2008 and formal approval rescinded in 2009 — the FDA confirmed in 2013 that the withdrawal was not for safety or efficacy reasons. Still compounded in the US through 503A/503B pharmacies.
For research purposes only. Not medical advice.
Modern Research Peptides currently lists Sermorelin at $4.70/mg, the lowest indexed price across 13 tracked research peptide vendors.
Sermorelin ranges from $4.70/mg to $10.00/mg across 21 listings from 13 research peptide vendors, normalized to USD per milligram and refreshed daily.
13 research peptide vendors currently list Sermorelin on PeptideScouter, with 11 in stock right now. We track 21 active listings across size and kit variants.
Sermorelin's CAS Registry Number is 86168-78-7. It is also sold as Sermo, SERMORLIN.
